MC3R links nutritional state to childhood growth and the timing of puberty.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
11 2021
Historique:
received: 17 12 2020
accepted: 01 10 2021
pubmed: 5 11 2021
medline: 29 3 2022
entrez: 4 11 2021
Statut: ppublish

Résumé

The state of somatic energy stores in metazoans is communicated to the brain, which regulates key aspects of behaviour, growth, nutrient partitioning and development

Identifiants

pubmed: 34732894
doi: 10.1038/s41586-021-04088-9
pii: 10.1038/s41586-021-04088-9
pmc: PMC8819628
mid: NIHMS1771752
doi:

Substances chimiques

IGF1 protein, human 0
MC3R protein, human 0
Mc3r protein, mouse 0
Melanocortins 0
Receptor, Melanocortin, Type 3 0
Insulin-Like Growth Factor I 67763-96-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-441

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : F32 HD105386
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/2
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK126715
Pays : United States
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : K99 DK127065
Pays : United States
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : F32 DK123879
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/5
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : F32 HD095620
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK070332
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/2
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK106476
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12012/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Friedman, J. M. The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 60, S1–S14; discussion S68–S84, S85–S87 (2002).
pubmed: 12403078 doi: 10.1301/002966402320634878
Cone, R. D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571–578 (2005).
pubmed: 15856065 doi: 10.1038/nn1455
Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484 (2001).
pubmed: 11373681 doi: 10.1038/35078085
Hill, J. W. et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 11, 286–297 (2010).
pubmed: 20374961 pmcid: 2854520 doi: 10.1016/j.cmet.2010.03.002
Varela, L. & Horvath, T. L. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 13, 1079–1086 (2012).
pubmed: 23146889 pmcid: 3512417 doi: 10.1038/embor.2012.174
Chen, A. S. et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res. 9, 145–154 (2000).
pubmed: 10951699 doi: 10.1023/A:1008983615045
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J. & Cone, R. D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165–168 (1997).
pubmed: 8990120 doi: 10.1038/385165a0
Vaisse, C., Clement, K., Guy-Grand, B. & Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20, 113–114 (1998).
pubmed: 9771699 doi: 10.1038/2407
Yeo, G. S. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111–112 (1998).
pubmed: 9771698 doi: 10.1038/2404
Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131–141 (1997).
pubmed: 9019399 doi: 10.1016/S0092-8674(00)81865-6
Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085–1095 (2003).
pubmed: 12646665 doi: 10.1056/NEJMoa022050
Krakoff, J. et al. Lower metabolic rate in individuals heterozygous for either a frameshift or a functional missense MC4R variant. Diabetes 57, 3267–3272 (2008).
pubmed: 18835933 pmcid: 2584132 doi: 10.2337/db08-0577
Brown, P. I. & Brasel, J. in The Malnourished Child Nestlé Nutrition Workshop Series (eds Lewinter-Suskind, L. & Suskind, R. M.) 213–228 (Nestlé Nutrition Institute and Vevey/Raven Press, 1990).
Clement, K. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398–401 (1998).
pubmed: 9537324 doi: 10.1038/32911
Strobel, A., Issad, T., Camoin, L., Ozata, M. & Strosberg, A. D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18, 213–215 (1998).
pubmed: 9500540 doi: 10.1038/ng0398-213
Roselli-Rehfuss, L. et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl Acad. Sci. USA 90, 8856–8860 (1993).
pubmed: 8415620 pmcid: 47459 doi: 10.1073/pnas.90.19.8856
Gantz, I. et al. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 8246–8250 (1993).
pubmed: 8463333 doi: 10.1016/S0021-9258(18)53088-X
Butler, A. A. et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518–3521 (2000).
pubmed: 10965927 doi: 10.1210/endo.141.9.7791
Chen, A. S. et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97–102 (2000).
pubmed: 10973258 doi: 10.1038/79254
Renquist, B. J. et al. Melanocortin-3 receptor regulates the normal fasting response. Proc. Natl Acad. Sci. USA 109, E1489–E1498 (2012).
pubmed: 22573815 pmcid: 3384161 doi: 10.1073/pnas.1201994109
Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014).
pubmed: 25282103 pmcid: 4250049 doi: 10.1038/ng.3097
Day, F. R. et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat. Genet. 49, 834–841 (2017).
pubmed: 28436984 pmcid: 5841952 doi: 10.1038/ng.3841
Demidowich, A. P., Jun, J. Y. & Yanovski, J. A. Polymorphisms and mutations in the melanocortin-3 receptor and their relation to human obesity. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 2468–2476 (2017).
pubmed: 28363697 doi: 10.1016/j.bbadis.2017.03.018
Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017).
pubmed: 28146470 pmcid: 5302847 doi: 10.1038/nature21039
Mencarelli, M. et al. Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum. Mol. Genet. 20, 392–399 (2011).
pubmed: 21047972 doi: 10.1093/hmg/ddq472
Zegers, D. et al. Identification of three novel genetic variants in the melanocortin-3 receptor of obese children. Obesity (Silver Spring) 19, 152–159 (2011).
doi: 10.1038/oby.2010.127
Lee, Y. S., Poh, L. K. & Loke, K. Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 87, 1423–1426 (2002).
pubmed: 11889220 doi: 10.1210/jcem.87.3.8461
Studenski, S. A. et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A Biol. Sci. Med. Sci. 69, 547–558 (2014).
pubmed: 24737557 pmcid: 3991146 doi: 10.1093/gerona/glu010
Kim, T. N. et al. Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk. Sci. Rep. 7, 6491 (2017).
pubmed: 28747657 pmcid: 5529503 doi: 10.1038/s41598-017-06831-7
Boyd, A. et al. Cohort profile: the ‘children of the 90s’-the index offspring of the Avon Longitudinal Study of Parents and Children. Int. J. Epidemiol. 42, 111–127 (2013).
pubmed: 22507743 doi: 10.1093/ije/dys064
Wade, K. H. et al. Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort. Nat. Med. 27, 1088–1096 (2021).
pubmed: 34045736 pmcid: 7611835 doi: 10.1038/s41591-021-01349-y
Lotta, L. A. et al. A cross-platform approach identifies genetic regulators of human metabolism and health. Nat. Genet. 53, 54–64 (2021).
pubmed: 33414548 doi: 10.1038/s41588-020-00751-5
Khaw, K. T. et al. Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med. 5, e12 (2008).
pubmed: 18184033 pmcid: 2174962 doi: 10.1371/journal.pmed.0050012
Pietzner, M. et al. Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat. Med. 27, 471–479 (2021).
pubmed: 33707775 pmcid: 8127079 doi: 10.1038/s41591-021-01266-0
Tapanainen, J. et al. Short and long term effects of growth hormone on circulating levels of insulin-like growth factor-I (IGF-I), IGF-binding protein-1, and insulin: a placebo-controlled study. J. Clin. Endocrinol. Metab. 73, 71–74 (1991).
pubmed: 1710624 doi: 10.1210/jcem-73-1-71
Finer, S. et al. Cohort profile: East London Genes & Health (ELGH), a community-based population genomics and health study in British Bangladeshi and British Pakistani people. Int. J. Epidemiol. 49, 20–21i (2020).
pubmed: 31504546 doi: 10.1093/ije/dyz174
de Onis, M. et al. Development of a WHO growth reference for school-aged children and adolescents. Bull. World Health Organ. 85, 660–667 (2007).
pubmed: 18026621 pmcid: 2636412 doi: 10.2471/BLT.07.043497
Campbell, J. N. et al. A molecular census of arcuate hypothalamus and median eminence cell types. Nat. Neurosci. 20, 484–496 (2017).
pubmed: 28166221 pmcid: 5323293 doi: 10.1038/nn.4495
Sweeney, P. et al. The melanocortin-3 receptor is a pharmacological target for the regulation of anorexia. Sci. Transl. Med. 13, eabd6434 (2021).
pubmed: 33883274 doi: 10.1126/scitranslmed.abd6434
Lam, B. Y. H. et al. Heterogeneity of hypothalamic pro-opiomelanocortin-expressing neurons revealed by single-cell RNA sequencing. Mol. Metab. 6, 383–392 (2017).
pubmed: 28462073 pmcid: 5404100 doi: 10.1016/j.molmet.2017.02.007
Romanov, R. A. et al. Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes. Nat. Neurosci. 20, 176–188 (2017).
pubmed: 27991900 doi: 10.1038/nn.4462
Chen, R., Wu, X., Jiang, L. & Zhang, Y. Single-cell RNA-seq reveals hypothalamic cell diversity. Cell Rep. 18, 3227–3241 (2017).
pubmed: 28355573 pmcid: 5782816 doi: 10.1016/j.celrep.2017.03.004
Backholer, K. et al. Kisspeptin cells in the ewe brain respond to leptin and communicate with neuropeptide Y and proopiomelanocortin cells. Endocrinology 151, 2233–2243 (2010).
pubmed: 20207832 doi: 10.1210/en.2009-1190
Cocchi, D., De Gennaro Colonna, V., Bagnasco, M., Bonacci, D. & Muller, E. E. Leptin regulates GH secretion in the rat by acting on GHRH and somatostatinergic functions. J. Endocrinol. 162, 95–99 (1999).
pubmed: 10396025 doi: 10.1677/joe.0.1620095
Tannenbaum, G. S., Gurd, W. & Lapointe, M. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 139, 3871–3875 (1998).
pubmed: 9724042 doi: 10.1210/endo.139.9.6206
Wang, L. & Moenter, S. M. Differential roles of hypothalamic AVPV and arcuate kisspeptin neurons in estradiol feedback regulation of female reproduction. Neuroendocrinology 110, 172–184 (2020).
pubmed: 31466075 doi: 10.1159/000503006
Dunger, D. B., Ahmed, M. L. & Ong, K. K. Effects of obesity on growth and puberty. Best Pract. Res. Clin. Endocrinol. Metab. 19, 375–390 (2005).
pubmed: 16150381 doi: 10.1016/j.beem.2005.04.005
Hauspie, R. C., Vercauteren, M. & Susanne, C. Secular changes in growth and maturation: an update. Acta Paediatr. Suppl. 423, 20–27 (1997).
pubmed: 9401534 doi: 10.1111/j.1651-2227.1997.tb18364.x
Kuhnen, P. et al. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N. Engl. J. Med. 375, 240–246 (2016).
pubmed: 27468060 doi: 10.1056/NEJMoa1512693
Roa, J. & Herbison, A. E. Direct regulation of GnRH neuron excitability by arcuate nucleus POMC and NPY neuron neuropeptides in female mice. Endocrinology 153, 5587–5599 (2012).
pubmed: 22948210 doi: 10.1210/en.2012-1470
Manfredi-Lozano, M. et al. Defining a novel leptin–melanocortin–kisspeptin pathway involved in the metabolic control of puberty. Mol. Metab. 5, 844–857 (2016).
pubmed: 27688998 pmcid: 5034608 doi: 10.1016/j.molmet.2016.08.003
Salomon, F., Cuneo, R. C., Hesp, R. & Sonksen, P. H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321, 1797–1803 (1989).
pubmed: 2687691 doi: 10.1056/NEJM198912283212605
Doherty, T. J. Invited review: aging and sarcopenia. J. Appl. Physiol. 95, 1717–1727 (2003).
pubmed: 12970377 doi: 10.1152/japplphysiol.00347.2003
McCance, R. A. & Widdowson, E. M. The determinants of growth and form. Proc. R. Soc. Lond. B Biol. Sci. 185, 1–17 (1974).
pubmed: 4149051 doi: 10.1098/rspb.1974.0001
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379 pmcid: 4380465 doi: 10.1371/journal.pmed.1001779
Eastwood, S. V. et al. Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank. PLoS ONE 11, e0162388 (2016).
pubmed: 27631769 pmcid: 5025160 doi: 10.1371/journal.pone.0162388
Powell, R. M. et al. Development and validation of total and regional body composition prediction equations from anthropometry and single frequency segmental bioelectrical impedance with DEXA. Preprint at medRxiv https://doi.org/10.1101/2020.12.16.20248330 (2020).
Zhao, Y. et al. GIGYF1 loss of function is associated with clonal mosaicism and adverse metabolic health. Nat. Commun. 12, 4178 (2021).
pubmed: 34234147 pmcid: 8263756 doi: 10.1038/s41467-021-24504-y
McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
pubmed: 27268795 pmcid: 4893825 doi: 10.1186/s13059-016-0974-4
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886–D894 (2019).
pubmed: 30371827 doi: 10.1093/nar/gky1016
Loh, P. R. et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47, 284–290 (2015).
pubmed: 25642633 pmcid: 4342297 doi: 10.1038/ng.3190
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Van Hout, C. V. et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature 586, 749–756 (2020).
pubmed: 33087929 pmcid: 7759458 doi: 10.1038/s41586-020-2853-0
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Millard, L. A. C., Davies, N. M., Gaunt, T. R., Davey Smith, G. & Tilling, K. Software application profile: PHESANT: a tool for performing automated phenome scans in UK Biobank. Int. J. Epidemiol. 47, 29–35 (2018).
pubmed: 29040602 doi: 10.1093/ije/dyx204
Ghoussaini, M. et al. Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 49, D1311–D1320 (2021).
Elsworth, B. et al. The MRC IEU OpenGWAS data infrastructure. Preprint at bioRxiv https://doi.org/10.1101/2020.08.10.244293 (2020).
McInnes, G. et al. Global Biobank Engine: enabling genotype–phenotype browsing for biobank summary statistics. Bioinformatics 35, 2495–2497 (2019).
pubmed: 30520965 doi: 10.1093/bioinformatics/bty999
Kamat, M. A. et al. PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations. Bioinformatics 35, 4851–4853 (2019).
pubmed: 31233103 pmcid: 6853652 doi: 10.1093/bioinformatics/btz469
Howe, L. D. et al. Changes in ponderal index and body mass index across childhood and their associations with fat mass and cardiovascular risk factors at age 15. PLoS ONE 5, e15186 (2010).
pubmed: 21170348 pmcid: 2999567 doi: 10.1371/journal.pone.0015186
Frysz, M., Howe, L. D., Tobias, J. H. & Paternoster, L. Using SITAR (superimposition by translation and rotation) to estimate age at peak height velocity in Avon Longitudinal Study of Parents and Children. Wellcome Open Res. 3, 90 (2018).
pubmed: 30345378 pmcid: 6171559 doi: 10.12688/wellcomeopenres.14708.1
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at arXiv https://export.arxiv.org/abs/1303.3997 (2013).
Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568–576 (2012).
pubmed: 22300766 pmcid: 3290792 doi: 10.1101/gr.129684.111
Wade, K. H. et al. Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort. Nat. Med. 27, 1088–1096 (2021).
pubmed: 34045736 pmcid: 7611835 doi: 10.1038/s41591-021-01349-y
Lindsay, T. et al. Descriptive epidemiology of physical activity energy expenditure in UK adults (the Fenland study). Int. J. Behav. Nutr. Phys. Act. 16, 126 (2019).
pubmed: 31818302 pmcid: 6902569 doi: 10.1186/s12966-019-0882-6
Williams, S. A. et al. Plasma protein patterns as comprehensive indicators of health. Nat. Med. 25, 1851–1857 (2019).
pubmed: 31792462 pmcid: 6922049 doi: 10.1038/s41591-019-0665-2
Pietzner, M. et al. Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nat. Commun. 11, 6397 (2020).
pubmed: 33328453 pmcid: 7744536 doi: 10.1038/s41467-020-19996-z
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
Day, N. et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br. J. Cancer 80 95–103 (1999).
pubmed: 10466767
Narasimhan, V. M. et al. Health and population effects of rare gene knockouts in adult humans with related parents. Science 352, 474–477 (2016).
pubmed: 26940866 pmcid: 4985238 doi: 10.1126/science.aac8624
Bayraktar, O. A. et al. Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map. Nat. Neurosci. 23, 500–509 (2020).
pubmed: 32203496 pmcid: 7116562 doi: 10.1038/s41593-020-0602-1
Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).
pubmed: 29203879 pmcid: 5715110 doi: 10.1038/s41598-017-17204-5
Schmidt, U., Weigert, M., Broaddus, C. & Myers, G. Cell Detection with Star-Convex Polygons in MICCAI 2018265–273 (Springer Nature Switzerland, 2018)
Widmann, J. et al. RNASTAR: an RNA structural alignment repository that provides insight into the evolution of natural and artificial RNAs. RNA 18, 1319–1327 (2012).
pubmed: 22645380 pmcid: 3383963 doi: 10.1261/rna.032052.111
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902.e21 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031

Auteurs

B Y H Lam (BYH)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

A Williamson (A)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

S Finer (S)

Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

F R Day (FR)

MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

J A Tadross (JA)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Department of Pathology, University of Cambridge, Cambridge, UK.

A Gonçalves Soares (A)

MRC Integrative Epidemiology Unit and Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

K Wade (K)

MRC Integrative Epidemiology Unit and Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

P Sweeney (P)

Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.

M N Bedenbaugh (MN)

Department of Molecular Physiology and Biophysics, School of Medicine, Vanderbilt University, Nashville, TN, USA.

D T Porter (DT)

Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.

A Melvin (A)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

K L J Ellacott (KLJ)

Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK.

R N Lippert (RN)

Department of Neurocircuit Development and Function, German Institute of Human Nutrition, Potsdam, Germany.

S Buller (S)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

J Rosmaninho-Salgado (J)

Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

G K C Dowsett (GKC)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

K E Ridley (KE)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

Z Xu (Z)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

I Cimino (I)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

D Rimmington (D)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

K Rainbow (K)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

K Duckett (K)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

S Holmqvist (S)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

A Khan (A)

Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

X Dai (X)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

E G Bochukova (EG)

Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

R C Trembath (RC)

School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

H C Martin (HC)

Wellcome Sanger Institute, Hinxton, Cambridge, UK.

A P Coll (AP)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

D H Rowitch (DH)

Department of Paediatrics, University of Cambridge, Cambridge, UK.

N J Wareham (NJ)

MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

D A van Heel (DA)

Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.

N Timpson (N)

MRC Integrative Epidemiology Unit and Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

R B Simerly (RB)

Department of Molecular Physiology and Biophysics, School of Medicine, Vanderbilt University, Nashville, TN, USA.

K K Ong (KK)

MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Department of Paediatrics, University of Cambridge, Cambridge, UK.

R D Cone (RD)

Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
Department of Molecular and Integrative Physiology, School of Medicine, University of Michigan, Ann Arbor, MI, USA.

C Langenberg (C)

MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.

J R B Perry (JRB)

MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

G S Yeo (GS)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK.

S O'Rahilly (S)

MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK. so104@medschl.cam.ac.uk.
NIHR Cambridge Biomedical Research Centre, Cambridge, UK. so104@medschl.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH